Ribozyme- and Deoxyribozyme-Strategies for Medical Applications
Journal:
Current Drug Targets
Volume:
5
Page:
667-681
Author(s):
S. Schubert and J. Kurreck
Extracellular Tropomyosin: A Novel Common Pathway Target for Anti- Angiogenic Therapy
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
543-553
Author(s):
Fernando Donate, Keith McCrae, David E. Shaw and Andrew P. Mazar
The Expanding Role of Tumor Necrosis Factor-α Inhibitors in the Management of Rheumatic Diseases
Journal:
Medicinal Chemistry Reviews - Online (Discontinued)
Volume:
1
Page:
479-491
Author(s):
Yasser El Miedany
Transcription Factors in Autoimmune Diseases
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2787-2796
Author(s):
Martin Eggert, Andreas Kluter, Uwe K. Zettl and Gunther Neeck
The NF-kB Pathway as a Potential Target for Autoimmune Disease Therapy
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2827-2837
Author(s):
Susanne Bacher and M. Lienhard Schmitz
The Role of Nitric Oxide in Autoimmune Diseases
Journal:
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents
Volume:
3
Page:
223-238
Author(s):
Klaus-Dietrich Kroncke
Pleiotropic Actions of PPARg Activators Thiazolidinediones in Cardiovascular Diseases
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2779-2786
Author(s):
Hiroyuki Takano, Hiroshi Hasegawa, Yunzeng Zou and Issei Komuro
The Design and Synthesis of Aryl Hydroxamic Acid Inhibitors of MMPs and TACE
Journal:
Current Topics in Medicinal Chemistry
Volume:
4
Page:
1289-1310
Author(s):
Jeremy I. Levin
Development of New Drugs in Angiogenesis
Journal:
Current Drug Targets
Volume:
5
Page:
485-493
Author(s):
Marina Ziche, Sandra Donnini and Lucia Morbidelli
Novel Molecular Targets for Systemic Lupus Erythematosus and Other Immune-Complex and T-Cell Mediated Autoimmune Diseases - Update
Journal:
Medicinal Chemistry Reviews - Online (Discontinued)
Volume:
1
Page:
331-332
Author(s):
Maria Marino and Giorgio Fassina